1. Home
  2. SEI vs ELVN Comparison

SEI vs ELVN Comparison

Compare SEI & ELVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SEI
  • ELVN
  • Stock Information
  • Founded
  • SEI 2014
  • ELVN 2016
  • Country
  • SEI United States
  • ELVN United States
  • Employees
  • SEI N/A
  • ELVN N/A
  • Industry
  • SEI
  • ELVN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SEI
  • ELVN Health Care
  • Exchange
  • SEI NYSE
  • ELVN Nasdaq
  • Market Cap
  • SEI 1.1B
  • ELVN 1.1B
  • IPO Year
  • SEI 2017
  • ELVN 2020
  • Fundamental
  • Price
  • SEI $26.87
  • ELVN $22.47
  • Analyst Decision
  • SEI Strong Buy
  • ELVN Strong Buy
  • Analyst Count
  • SEI 2
  • ELVN 5
  • Target Price
  • SEI $30.00
  • ELVN $37.80
  • AVG Volume (30 Days)
  • SEI 889.9K
  • ELVN 204.7K
  • Earning Date
  • SEI 02-16-2025
  • ELVN 11-13-2024
  • Dividend Yield
  • SEI 1.79%
  • ELVN N/A
  • EPS Growth
  • SEI N/A
  • ELVN N/A
  • EPS
  • SEI 0.43
  • ELVN N/A
  • Revenue
  • SEI $280,141,000.00
  • ELVN N/A
  • Revenue This Year
  • SEI $9.54
  • ELVN N/A
  • Revenue Next Year
  • SEI $64.93
  • ELVN N/A
  • P/E Ratio
  • SEI $62.32
  • ELVN N/A
  • Revenue Growth
  • SEI N/A
  • ELVN N/A
  • 52 Week Low
  • SEI $6.59
  • ELVN $10.90
  • 52 Week High
  • SEI $32.61
  • ELVN $30.03
  • Technical
  • Relative Strength Index (RSI)
  • SEI N/A
  • ELVN 39.53
  • Support Level
  • SEI N/A
  • ELVN $21.84
  • Resistance Level
  • SEI N/A
  • ELVN $24.42
  • Average True Range (ATR)
  • SEI 0.00
  • ELVN 1.59
  • MACD
  • SEI 0.00
  • ELVN -0.05
  • Stochastic Oscillator
  • SEI 0.00
  • ELVN 18.27

About SEI SOLARIS ENERGY INFRASTRUCTURE INC

Solaris Energy Infrastructure Inc provides services in the oil and gas industry. Its solutions are Solaris software suite, Fluid management system, Automated control systems, Field services, Last mile management, Wet sand solutions, Power Solutions, and Integrated wellsite solution.

About ELVN Enliven Therapeutics Inc.

Enliven Therapeutics Inc is a clinical-stage precision oncology company focused on the discovery and development of potentially first-in-class precision oncology therapies. Enliven's programs are designed to address issues such as tolerability, combinability, resistance and disease escape through brain metastases. Its product candidates include ELVN-001 which is a potent, selective, small molecule kinase inhibitor designed to specifically target the BCR-ABL gene fusion, the oncogenic driver for patients with chronic myeloid leukemia, and the ELVN-002 which is central nervous system (CNS) penetrant and irreversible HER2 inhibitor with activity against wild type HER2 and various HER2 mutations.

Share on Social Networks: